CClinicalTrials.gg
CompletedNCT05950243Updated Jan 27, 2025

COVID-19 Disease & Vaccine Survey in Africa

An observational study in COVID-19 and Vaccine Hesitancy, sponsored by Salem Anaesthesia Pain Clinic. Completed at 1 site in Canada. Open to participants aged 9 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-27.

Sponsored by Salem Anaesthesia Pain Clinic · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
9 Years to 99 Years
Sex
All
01

Study summary

The COVID-19 pandemic is a public health concern; for which the WHO recommends protective measures and vaccination. There is inadequate data on the impact of COVID-19 vaccination and control measures in Africa. This survey is collecting data about people's knowledge, attitude and compliance regarding COVID-19 disease and vaccines.

Read the detailed description

The coronavirus disease 2019 (COVID-19) pandemic remains a major public health concern. There is inadequate data on the epidemiology of COVID-19 in Africa. There are emerging COVID-19 variants with high transmissibility and morbidity. The World Health Organization (WHO) recommends protective measures and vaccination; for the control of COVID-19. There is inadequate data on the impact of COVID-19 vaccination and control measures in many nations in Africa.

This study is a survey of specific urban populations in sub-Saharan Africa. The anonymized survey is collecting data about people's knowledge and attitude regarding COVID-19 disease or control measures. The survey is also collecting data about people's knowledge, attitude and compliance regarding COVID-19 vaccines. The study uses a validated questionnaire to collect data. The study aims to inform and improve COVID-19 management or control in Africa.

02

Conditions studied

  • COVID-19
  • Vaccine Hesitancy

Browse trials for

Keywords

  • COVID-19
03

In context

COVID-19

7,638 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 1,000 is above the median of 260 across 3,135 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Salem Anaesthesia Pain Clinic is the lead sponsor of 19 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Urban population in selected sub-Saharan African town or city

Inclusion criteria

  • urban population in Africa
  • people in sub-Saharan Africa town

Exclusion criteria

Exclusion Criteria:

  • rural population
  • people outside sub-Saharan Africa
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (actual)
Patient registry
No

Groups and cohorts

  • Urban population Africa

    Urban population in sub-Saharan Africa

    Behavioral: Questionnaire

Interventions

  • BehavioralQuestionnaire

    Questionnaire survey for data collection

06

What researchers measure

Primary outcomes

  1. Percentage of people who know about COVID-19 prevention

    Percentage of people who know about COVID-19 preventive measures

    Time frame: 6 months

  2. Percentage of people who received COVID-19 vaccination

    Percentage of people who received COVID-19 vaccination, 1st and 2nd doses

    Time frame: 6 months

07

Study locations

1 site
  • Salem Anaesthesia Pain Clinic
    Surrey, British Columbia V3S 7J1, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05950243
Lead sponsor
Salem Anaesthesia Pain Clinic
Responsible party
Sponsor
First posted
Jul 18, 2023
Start date
Jan 2, 2021
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Jan 27, 2025

Study contacts

Olu Bamgbade, MD,FRCPC
principal investigator · Salem Anaesthesia Pain Clinic

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion